Overall rank by patents
#32,612
of 49,997 tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Neurim Pharmaceuticals (1991) Ltd.
USPTO PatentsView assignee record - 8 granted patents across 7 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Neurim ranks #32,612 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 7 technology areas.
- #32,612
- of 49,997 US assignees by volume
- Top 23%
- by Innovation Score (45.6/100)
- 14.4
- avg claims per patent
- -40%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R32612 · Foreign Corporation #32,612 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 8 grants
- MID-PACK #32,612/49,997
- PHOTO-FINISH NEO Design
- CPC-NARROW A61P · 7 areas
- INNOV-PAR 45.6/100
- CLAIMS-RICH 14.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -40% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: NEO Design, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Innovation-score neighbourhood around Neurim
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Neurim Pharmaceutica… · this assignee
Neurim Pharmaceutica… · this assignee
46 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Neurim's Innovation Score is 45.6/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Where Neurim's grants concentrate
Neurim Pharmaceuticals (1991) Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 75% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2016. By volume, Neurim sits between NEO Design, LLC and NEW Flyer Industries Canada ULC.
Neurim's three-year grant acceleration
Neurim Pharmaceuticals (1991) Ltd. shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Neurim's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- NEO Design
NEO Design, LLC
8 patents
- Neosapience
Neosapience, Inc.
8 patents
- Netherlands Trans…
Netherlands Translational Research Center B.V.
8 patents
- Netimpact Strateg…
Netimpact Strategies, Inc.
8 patents
- Neurovive Pharmac…
Neurovive Pharmaceutical AB
8 patents
- Neusoft Reach Aut…
Neusoft Reach Automotive Technology (SHANGHAI) Co., Ltd.
8 patents
- Neviot-nature OF…
Neviot-nature OF Galilee Ltd
8 patents
- NEW Flyer Industr…
NEW Flyer Industries Canada ULC
8 patents
- Neurim Pharmaceut… ◀
Neurim Pharmaceuticals (1991) Ltd.
8 patents
What this shows Neurim holds 8 patents at rank #32,580, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Neurim
By rank, the assignees closest to #32,580 in granted patent volume.
- NEO Design, LLC #32,576 · 8 patents
- Neosapience, Inc. #32,577 · 8 patents
- Netherlands Translational Research Center B.V. #32,578 · 8 patents
- Netimpact Strategies, Inc. #32,579 · 8 patents
- Neurovive Pharmaceutical AB #32,581 · 8 patents
- Neusoft Reach Automotive Technology (SHANGHAI) Co., Ltd. #32,582 · 8 patents
- Neviot-nature OF Galilee Ltd #32,583 · 8 patents
- NEW Flyer Industries Canada ULC #32,584 · 8 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Neurim's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Neurim's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 23% higher than 77% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 50.0% |
| 2016 | 1 | 12.5% |
| 2023 | 2 | 25.0% |
| 2024 | 1 | 12.5% |
Which technologies does Neurim Pharmaceuticals (1991) Ltd. patent most?
Top 7 of 7 technology areas
What to do with this data
Neurim Pharmaceuticals (1991) Ltd.'s patent record in context - here's where to go next.
- Neurim Pharmaceuticals (1991) Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 75% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #32,612 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Neurim Pharmaceuticals (1991) Ltd. against NEO Design, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 45.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.